REDNESS SOLUTIONS MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY- octinoxate, titanium dioxide, and zinc oxide lotion 
CLINIQUE LABORATORIES LLC

----------

REDNESS SOLUTIONS MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY

Drug Facts

Active ingredients

Octinoxate 5.9%
Titanium Dioxide 3.7%
Zinc Oxide 2.9%

Purpose

Sunscreen

Use

helps prevent sunburn

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

Inactive ingredients

water\aqua\eau • methyl trimethicone • phenyl trimethicone • dimethicone • triethylhexanoin • butylene glycol • trimethylsiloxysilicate • peg-10 dimethicone • lauryl peg-9 polydimethylsiloxyethyl dimethicone • aluminum hydroxide • c12-15 alkyl benzoate • lactobacillus ferment • citrus grandis (grapefruit) peel extract • magnolia grandiflora bark extract • poria cocos sclerotium extract • astrocaryum murumuru seed butter • glycerin • caffeine • sodium myristoyl sarcosinate • caprylyl methicone • methicone • polyglyceryl-6 polyricinoleate • disteardimonium hectorite • acetyl glucosamine • isopropyl titanium triisostearate • dimethicone crosspolymer-3 • lecithin • tocopheryl acetate • laureth-7 • dimethicone/peg-10/15 crosspolymer • sodium chloride • dipropylene glycol • disodium edta • polyaminopropyl biguanide • phenoxyethanol • [+/- mica • titanium dioxide (ci 77891) • iron oxides (ci 77491, ci 77492, ci 77499)] [iln37592]

Other information

protect the product in this container from excessive heat and direct sun

PRINCIPAL DISPLAY PANEL - 30 ml Bottle Carton

CLINIQUE

redness
solutions

makeup
broad spectrum
SPF 15
with probiotic technology

1 FL.OZ.LIQ./30 ml e

PRINCIPAL DISPLAY PANEL - 30 ml Bottle Carton
REDNESS SOLUTIONS MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY 
octinoxate, titanium dioxide, and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-070
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE59 mg  in 1 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE37 mg  in 1 mL
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE29 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
METHYL TRIMETHICONE (UNII: S73ZQI0GXM)  
WATER (UNII: 059QF0KO0R)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0)  
LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: 25G622K2RA)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
LIMOSILACTOBACILLUS REUTERI (UNII: 9913I24QEE)  
GRAPEFRUIT (UNII: O82C39RR8C)  
ASTROCARYUM MURUMURU SEED BUTTER (UNII: 12V64UPU6R)  
GLYCERIN (UNII: PDC6A3C0OX)  
CAFFEINE (UNII: 3G6A5W338E)  
SODIUM MYRISTOYL SARCOSINATE (UNII: J07237209D)  
CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
METHICONE (20 CST) (UNII: 6777U11MKT)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
N-ACETYLGLUCOSAMINE (UNII: V956696549)  
ISOPROPYL TITANIUM TRIISOSTEARATE (UNII: 949E3KBJ1I)  
LAURETH-7 (UNII: Z95S6G8201)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
MICA (UNII: V8A1AW0880)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-070-011 in 1 CARTON12/01/2011
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02012/01/2011
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder N.V.370151326manufacture(49527-070) , pack(49527-070) , label(49527-070)

Revised: 10/2023
Document Id: 079bb65e-7a6e-6c0a-e063-6294a90ab33a
Set id: e557e7f3-1fa7-4dde-977f-fe3f942496c0
Version: 6
Effective Time: 20231013
 
CLINIQUE LABORATORIES LLC